oxybutynin has been researched along with Innate Inflammatory Response in 9 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robb, KP | 1 |
| Cotechini, T | 2 |
| Allaire, C | 1 |
| Sperou, A | 1 |
| Graham, CH | 2 |
| Feragalli, B | 1 |
| Dugall, M | 1 |
| Luzzi, R | 1 |
| Ledda, A | 1 |
| Hosoi, M | 1 |
| Belcaro, G | 1 |
| Cesarone, MR | 1 |
| van der Burg, NMD | 1 |
| Depelsenaire, ACI | 1 |
| Crichton, ML | 1 |
| Kuo, P | 1 |
| Phipps, S | 1 |
| Kendall, MAF | 1 |
| Hernandez-Juarez, J | 1 |
| Sanchez-Serrano, JC | 1 |
| Moreno-Hernandez, M | 1 |
| Alvarado-Moreno, JA | 1 |
| Hernandez-Lopez, JR | 1 |
| Isordia-Salas, I | 1 |
| Majluf-Cruz, A | 1 |
| Kalita, B | 1 |
| Das, MK | 1 |
| Sarma, M | 1 |
| Deka, A | 1 |
| Hu, Y | 1 |
| Wu, YY | 1 |
| Xia, XJ | 1 |
| Wu, Z | 1 |
| Liang, WQ | 1 |
| Gao, JQ | 1 |
| Adachi, H | 1 |
| Ioppolo, F | 1 |
| Paoloni, M | 1 |
| Santilli, V | 1 |
| Othman, M | 1 |
| Hessenberger, M | 1 |
| Weiss, R | 1 |
| Weinberger, EE | 1 |
| Boehler, C | 1 |
| Thalhamer, J | 1 |
| Scheiblhofer, S | 1 |
1 review available for oxybutynin and Innate Inflammatory Response
| Article | Year |
|---|---|
Physical characteristics, pharmacological properties and clinical efficacy of the ketoprofen patch: a new patch formulation.
Topics: Adhesiveness; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Chemistry, | 2011 |
8 other studies available for oxybutynin and Innate Inflammatory Response
| Article | Year |
|---|---|
Inflammation-induced fetal growth restriction in rats is associated with increased placental HIF-1α accumulation.
Topics: Animals; Disease Models, Animal; Female; Fetal Growth Retardation; Gene Expression Regulation; Gesta | 2017 |
Pycnogenol®: supplementary management of symptomatic osteoarthritis with a patch. An observational registry study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Flavonoids; Humans; Inflammation; Knee; Male | 2019 |
A low inflammatory, Langerhans cell-targeted microprojection patch to deliver ovalbumin to the epidermis of mouse skin.
Topics: Animals; Cell Movement; Cell Survival; Dermis; Drug Carriers; Drug Liberation; Epidermal Cells; Epid | 2019 |
Effects of the contraceptive skin patch and subdermal contraceptive implant on markers of endothelial cell activation and inflammation.
Topics: Adolescent; Adult; Biomarkers; C-Reactive Protein; Contraceptive Agents, Female; Drug Implants; Endo | 2015 |
Sustained Anti-inflammatory Effect of Resveratrol-Phospholipid Complex Embedded Polymeric Patch.
Topics: Acrylic Resins; Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Carrageenan; Chemistry | 2017 |
Development of drug-in-adhesive transdermal patch for α-asarone and in vivo pharmacokinetics and efficacy evaluation.
Topics: Acrylates; Adhesives; Allylbenzene Derivatives; Animals; Anisoles; Asthma; Biological Availability; | 2011 |
Nitroglycerin prevents coagulopathies and foetal death associated with abnormal maternal inflammation in rats.
Topics: Administration, Cutaneous; Animals; Blood Coagulation; Blood Coagulation Disorders; Etanercept; Fema | 2012 |
Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Allergens; Animals; Bronchoalveolar Lavage Fluid; | 2013 |